Showing results (1561-1570 of 1,892) with videos related to

Sort By:
Pageof 190
Scientific Reports|January 27, 2021
Sensitivity to food and cocaine cues are independent traits in a large sample of heterogeneous stock ratsChristopher P King, Jordan A Tripi, Alesa R Hughson, et al.
Journal of Oral Microbiology|November 19, 2014
Children with severe early childhood caries: streptococci genetic strains within carious and white spot lesionsKenneth Gilbert, Raphael Joseph, Alex Vo, et al.
Frontiers in Genetics|January 30, 2023
Genome-wide association study in a rat model of temperament identifies multiple loci for exploratory locomotion and anxiety-like traitsApurva S Chitre, Elaine K Hebda-Bauer, Peter Blandino, et al.
Clinical Pharmacology in Drug Development|May 1, 2023
A Phase 1 First-in-Human Pharmacokinetic and Pharmacodynamic Study of JNJ-64264681, a Covalent Inhibitor of Bruton's Tyrosine KinaseJocelyn H Leu, Xin Miao, Kevin Shalayda, et al.
Frontiers in Molecular Neuroscience|March 19, 2025
Bioenergetic-related gene expression in the hippocampus predicts internalizing vs. externalizing behavior in an animal model of temperamentElaine K Hebda-Bauer, Megan H Hagenauer, Daniel B Munro, et al.
Diabetes Care|January 19, 2022
Prediction of Major Adverse Cardiovascular Events From Retinal, Clinical, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort StudyIfy R Mordi, Emanuele Trucco, Mohammad Ghouse Syed, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
The selection and evaluation of new chelating agents for the treatment of iron overloadC G Pitt, G Gupta, W E Estes, et al.
Anesthesia and Analgesia|December 20, 2008
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolaseMark J Karbarz, Lin Luo, Leon Chang, et al.
Plos Genetics|May 31, 2022
Genetic characterization of outbred Sprague Dawley rats and utility for genome-wide association studiesAlexander F Gileta, Christopher J Fitzpatrick, Apurva S Chitre, et al.
JAMA Oncology|March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical TrialLocke J Bryan, Carla Casulo, Pamela B Allen, et al.
Pageof 190